At $2M, priciest medicine ever treats fatal disease in babies
The U.S. Food and Drug Administration approved a $2.1 million medication to treat a fatal disease in children — the most expensive treatment ever. The medicine, Zolgensma, by drugmaker Novartis, targets a condition called spinal muscular atrophy that weakens a…